• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Novartis Announces New Phase 3 Study for Spinal Muscular Atrophy Treatment in Elderly Patients americanpharmaceuticalreview
    August 04, 2021
    Novartis announced that the U.S. FDA determined that OAV-101 intrathecal (IT) clinical trials for spinal muscular atrophy (SMA) patients may proceed, thereby lifting the partial clinical trial hold initiated in October 2019.
  • STEER appoints Subodh Jindal as CEO expresspharma
    December 17, 2020
    He will be responsible for business strategy and plant operations for the engineering business with focused attention to fast-emerging fields of pharma continuous manufacturing solutions, plastic recycling solutions, and the food processing industry.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service